IP Verse

Method Of Treating Cancer Using Immune Checkpoint Inhibitor

Patent No. EP3322731 (titled "Method Of Treating Cancer Using Immune Checkpoint Inhibitor") was filed by Bristol Myers Squibb on Jul 14, 2016. The application was issued on Jan 13, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (9)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
APPLEYARD LEES FLECK BARBARAOct 13, 2021APPLEYARD LEES
GREINEROct 13, 2021GREINER
MAIWALDOct 13, 2021MAIWALD
BIONTECHOct 12, 2021THOMANN
MERCK SHARP & DOHMEOct 12, 2021MERCK SHARP & DOHME
PATENT BOUTIQUEOct 12, 2021PATENT BOUTIQUE
KRAUS & LEDERER PARTGMBBOct 7, 2021KRAUS & LEDERER PARTGMBB
REGENERON PHARMACEUTICALSOct 7, 2021J A KEMP
ISA PHARMACEUTICALSOct 6, 2021VAN DEN HAZEL

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3322731

BRISTOL MYERS SQUIBB
Application Number
EP16744626A
Filing Date
Jul 14, 2016
Status
Granted And Under Opposition
Dec 11, 2020
Publication Date
Jan 13, 2021
External Links
Slate, Register , Google Patents